MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    The development of an instrument for measuring Parkinson’s patient empowerment

    P. Viwattanakulvanid (Bangkok, Thailand)

    Objective: To develop a valid and reliable measurement scale of Parkinson’s patient empowerment index (PPEI). Background: Patient empowerment concept has been used as part of…
  • 2018 International Congress

    Change of Cognition Functions after Subthalamic Nucleus-Deep Brain Stimulationin in Parkinson’s Disease

    L. Wu, L. Chen (Guangzhou, China)

    Objective: To explore the changes of cognitive function in Parkinson disease (PD) patients with deep brain stimulation (DBS) of the subthalamic nucleus (STN). Background: STN-DBS…
  • 2018 International Congress

    Adult neurogenesis is impaired in pink1-/- zebrafish (Danio rerio)

    S. Bandmann, M. Keatinge, M. Placzek, O. Bandmann (Sheffield, United Kingdom)

    Objective: To determine whether PINK1 deficiency impairs adult neurogenesis in a tractable vertebrate model of PINK1-related Parkinson's disease (PD). Background: PD is characterized by loss…
  • 2018 International Congress

    Mitochondrial phenotype related to the A30P alpha-synuclein mutation as a patient-derived cellular model of Parkinson’s disease

    B. Santos, P. Barbuti, P. Antony, J. Arias, A. Hummel, J. Schwamborn, R. Krüger (Belval, Luxembourg)

    Objective: Our study aims to perform detailed phenotyping of the A30P alpha-synuclein familial case of PD, allowing to identify underlying mechanisms of the disease that…
  • 2018 International Congress

    A review of modifiers of Parkinsonism in the Leucine-rich repeat kinase 2 (LRRK2) population

    J. Staisch (Portland, OR, USA)

    Objective: To review and examine the most current identified modifiers of Parkinsonism in the LRRK2 population. Background: LRRK2 is a protein with multiple domains and…
  • 2018 International Congress

    Higher Levels of Serum Uric Acid Associated with Motor & Non-Motor Symptoms in Early Parkinson’s Disease

    N. Chia, W.L. Au, Z. Lu, X. Huang, S. Ng, S. Acharyya, F. Setiawan, E. Ng, K.Y. Tay, E.K. Tan, L. Tan (Singapore, Singapore)

    Objective: Uric acid (UA) has been shown to be potentially neuroprotective in Parkinson's disease (PD), a progressive neurodegenerative disorder that is clinically characterised by motor…
  • 2018 International Congress

    Identification and analysis of differential miRNA in exosomes of dopaminergic neurons overexpressing α-synuclein

    Y. Liang, D. Lin, T. Zhou, D. Zheng (Guangzhou, China)

    Objective: The aim of this study was to compare the miRNA expression in secreted exosomes from dopaminergic neurons overexpressing α-synuclein with healthy neurons. Background: Exosomes,…
  • 2018 International Congress

    White Matter Hyperintensities and Mortality among Patients with Parkinsonism in Olmsted County, MN (1995-2010)

    J. Yu, R. Brown, J. Huston, M. Mielke, C. stang, P. Turcano, R. Savica (Rochester, MN, USA)

    Objective: To examine white matter hyperintensity grade (WMHG) by parkinsonism type, and the association between WMHG and mortality among incident parkinsonism patients in a population-based…
  • 2018 International Congress

    Closed loop spinal cord stimulation restores locomotion and desynchronizes corticostriatal beta oscillations

    A. Yadav, E. Borda, M. Nicolelis (Durham, NC, USA)

    Objective: To test if closed loop Spinal Cord Stimulation (SCS) could be used to restore locomotion in a 6-hydroxydopamine (6-OHDA ) rodent model of Parkinson's…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #24475 (not found)
  • #23043 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • #24752 (not found)
  • Erotophonophilia and severe impulse control disorder in a patient with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley